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Sustained Benefit of Alternate Behavioral 
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A Randomized Clinical Trial
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John P. Allegrante , Stuart R. Lipsitz, Sundar Natarajan
ABSTRACT: Little is known about the long-term effects of behavioral interventions to improve blood pressure (BP) control. We 
evaluated whether a telephone-delivered, behavioral stage-matched intervention (SMI), or a nontailored health education 
intervention (HEI) delivered for 6 months improves BP control (or lowers systolic BP) over 12 months, as well as its 
sustainability 6 months after intervention implementation ended, compared with usual care in participants with repeated 
uncontrolled BP at baseline. A 3-arm, randomized controlled trial was designed to evaluate the effectiveness of 2 interventions, 
each compared with a usual-care control group. Participants were 533 adults with persistent uncontrolled BP who were 
treated at 2 Veterans Affairs Medical Centers. The intervention was implemented for 6 months, followed by 6 months of 
observation. Compared with usual care, the odds of having BP under control over 12 months in SMI were 84% higher (odds 
ratio, 1.84 [95% CI, 1.28–2.67]; P=0.001), and 48% higher in HEI (odds ratio, 1.48 [95% CI, 1.02–2.14]; P=0.04). Over 
the 12 months, compared with usual care, systolic blood pressure was 2.80 mm Hg lower in SMI ([95% CI, 0.27 to 5.33]; 
P=0.03) while it was 2.58 mm Hg lower in HEI ([95% CI, −0.40 to 5.55]; P=0.09). From 6 to 12 months, SMI sustained 
improved BP control and lower systolic blood pressure, while HEI, which did not have significantly better BP control or lower 
systolic blood pressure at 6 months, appeared to improve BP control and lower systolic blood pressure. SMI and HEI are 
promising interventions that can be implemented in clinical practice to improve BP management.
REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00286754. (Hypertension. 2021;77:1867–1876. 
DOI: 10.1161/HYPERTENSIONAHA.120.15192.) • Data Supplement
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Hypertension is highly prevalent and the primary risk factor for mortality.1 Despite its high risk and the availability of effective treatments, only 51.8% of 
adults have their blood pressure under control.2 Suc-
cessful management requires persistent adherence to 
lifestyle and medications to bring blood pressure (BP) 
consistently under control and thereby lower the mortal-
ity associated with it.3
Successive national and international committees 
have reviewed the evidence and recommended individ-
ualizing treatment, simplifying the medication dosing if 
possible, and counseling patients about the importance 
of diet, exercise, and sustained weight loss if obese.3–5 
Interventions targeting multiple behaviors, such as diet, 
medication-taking, and exercise simultaneously are asso-
ciated with stronger effects and can increase efficiency 
of behavioral interventions and reduce health costs.6
Behavioral interventions can improve BP.7 In a pre-
vious article, we reported on the 6-month effects of a 
novel, tailored intervention (using the Transtheoreti-
cal Model of health behavior change)8 or a nontailored 
health education intervention on BP control and systolic 
blood pressure (SBP).9 At 6 months, we found that the 
tailored transtheoretical stage-matched intervention 
(SMI) significantly improved BP control by 20% and low-
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The nontailored Health Education Intervention (HEI) led 
to a nonsignificant 8.5% improved BP control rate and a 
nonsignificant 2.9 mm Hg lower SBP compared with UC.
According to observational data, healthful behaviors 
in young adults lower cardiovascular risk in middle age10 
and BP lowering in middle age lowers lifetime risk of car-
diovascular disease.11 Little is known, however, about the 
sustainability of BP reductions achieved through behav-
ioral interventions.12 This article reports on the overall 
effects and the sustainability of the BP effects achieved 
in a 3-arm randomized clinical trial, which evaluated the 
effectiveness of 2 behavioral interventions (a stage of 
change matched education and a health education with-
out matching) and UC, in a patient population with persis-
tent uncontrolled hypertension at baseline. The behavioral 
interventions were discontinued after 6 months, and 6- 
to 12-month sustainability of the BP effect was evalu-
ated through prespecified analyses. Our objective was to 
evaluate whether the telephone-delivered, transtheoreti-
cal SMI, or the nontailored HEI that were both delivered 
for 6 months would lead to better BP control (or lower 
SBP) over 12 months as well as maintain its effects 6 
months after implementation of the intervention ended 
(sustainability) compared with UC in participants with 
repeated uncontrolled BP at enrollment.
MATERIALS AND METHODS
The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
Design, Setting, and Participants
We conducted a 3-arm randomized clinical trial to assess the 
effectiveness and sustainability of 2 active interventions on 
BP control and SBP, each intervention being compared with a 
usual-care control group with BP being measured at 0, 6, and 
12 months. The study was approved by the Institutional Review 
Board of the New York Harbor Healthcare System, and all par-
ticipants provided formal written informed consent. Participants 
were recruited from July 2006 through March 2009 in the out-
patient clinics in Brooklyn and Manhattan with follow-up being 
completed by August 2011.
Participants were eligible if they had hypertension, were on 
antihypertensive drug therapy for ≥6 months, and had uncon-
trolled BP during the previous clinic visit and during current 
screening.9 Consistent with the recommendations during 
the time period of the study (JNC VII), uncontrolled BP was 
defined as (1) SBP≥130 mm Hg or diastolic BP≥80 mm Hg 
in participants with diabetes or chronic kidney disease or (2) 
SBP≥140 mm Hg or diastolic BP≥90 mm Hg in all others. 
Participants with uncontrolled BP during their previous routine 
clinic visit were identified via electronic medical record search, 
approached during their subsequent visit, and informed about 
the study.9 Interested participants had their BP checked 3 
times during this screening, and those with uncontrolled BP 
(averaged) were invited to participate.9,13
Participants with recent cardiovascular disease (<6 months 
ago), Class III or IV heart failure, severe psychiatric illness, 
AIDS, tuberculosis, lupus, end-stage renal failure, or limited life 
Nonstandard Abbreviations and Acronyms
BP blood pressure
GEE generalized estimating equation
HEI health education intervention





• This randomized trial evaluated the overall effective-
ness (over 12 months) and sustainability (6 months 
after stopping intervention) of 2 telephone-delivered 
behavioral interventions on blood pressure (BP) con-
trol and systolic BP among veterans with persistent 
uncontrolled hypertension in the primary-care setting. 
The results show that stage of change-matched tele-
phone counseling is especially effective in facilitat-
ing adherence to diet, medication, and exercise that 
produced clinically meaningful improvements in BP 
and systolic BP control, which was sustained over the 
course of 1 year.
What Is Relevant?
• The stage-matched intervention group received tai-
lored counseling that targeted multiple behaviors 
associated with hypertension (ie, diet, medication, and 
exercise), consistent with national and international 
recommendations. The HEI group received nontailored 
education about hypertension as well as other health 
areas (eg, the flu shot). The UC group received stan-
dard health care for hypertension.
Summary
Overall, the stage-matched intervention had 84% 
greater odds of bringing BP under control while HEI 
had 48% greater odds of bringing BP under control 
compared with the usual care group over 12 months. 
Both the stage-matched intervention and the health 
education intervention were sustainable and thus are 
valuable approaches to lower systolic blood pressure 
and improve BP control rates.
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expectancy (<1 year) due to terminal illnesses were excluded 
as reported previously.9 Following enrollment, participants had 
a simple run-in period of 4 weeks during which period they 
were informed again about the study responsibilities and their 
telephone availability confirmed.13 After the run-in period, par-
ticipants had the initial baseline assessment (month 0) during 
which a research assistant measured resting BP (6× over a 
2-hour period using an Omron HEM-907XL automated BP 
machine), height, weight, and administered valid questionnaires 
assessing the dietary approaches to stop hypertension adher-
ence index (using the Willett food frequency questionnaire), 
aerobic exercise in minutes per week (from the Sallis 7-day 
physical activity recall), and medication adherence (from the 
Morisky adherence scale). The average of the 6 readings was 
used in statistical analyses.14,15 Participants also had serum and 
urine laboratory tests. A similar protocol was followed at 6 and 
12 months. All participants were given $20 at each visit to par-
tially reimburse them for their time and travel.
After the baseline data collection, participants were allo-
cated to one of the 3 study arms by block randomization strati-
fied by site (Manhattan or Brooklyn) and by dietary stage of 
change. At each site, randomization was in blocks of 6 such that 
for every 6 participants at a site, 2 were allocated to each arm. 
The random assignments were concealed. While participants 
knew that the study was evaluating telephone interventions 
to improve hypertension control, they did not know which of 
the 2 phone interventions they were receiving. This was fea-
sible because study participants did not have contact with each 
other. While counselors knew of the treatment assignments, 
they did not know the BP and adherence outcomes. Finally, 
research assistants who assessed outcomes were blinded to 
treatment assignment. Further details about the blinding proce-
dures are in Friedberg et al.16
Intervention
All study participants received information about hyperten-
sion and its treatment. The UC group did not receive monthly 
phone counseling. The SMI and HEI groups received monthly 
telephone counseling for 6 months. Participants did not 
receive counseling between 6 and 12 months and completed 
a final visit at 12 months post-randomization to assess BP 
and treatment adherence after counseling had been stopped 
for 6 months. All phone sessions were conducted by counsel-
ors with a Master’s degree or higher in psychology or a related 
field. Participants were randomized equally to the counsel-
ors such that each counselor conducted both HEI and SMI 
calls. All calls were recorded and a random sample assessed 
weekly for fidelity by the research team (ie, counselors, study 
coordinator, and PI).
Participants in SMI received tailored monthly phone coun-
seling for exercise, diet, and medications matched to their cur-
rent stage of change based on the Transtheoretical Model8 
using a computer-based intervention manual. During each call 
(≈30 minutes), stage of change for adherence to diet, medi-
cation, and exercise was assessed separately using validated 
stage of change questions.17 Counseling was tailored based on 
the stage of change assessment, which was used to determine 
which processes of change to use, and then counseling con-
ducted. For all participants, decisional balance, or the pros 
and cons of engaging in a behavior (eg, exercising regularly) 
was explored. Participants were also assessed for their self-
efficacy18 and then the counselor worked with the participant 
to problem-solve situations in which they had low self-efficacy 
to adhere to treatment recommendations. The dietary goal was 
the dietary approaches to stop hypertension diet,19,20 which 
we operationalized as following the dietary approaches to 
stop hypertension diet for >5 days per week (>80% adher-
ence). Before the 2008 Physical Activity Recommendations for 
Americans,21 the exercise goal was 20 to 60 minutes of mod-
erate to high-intensity exercise performed 3 or more times a 
week.22 Since the majority of participants were over the age of 
60 with many comorbidities in addition to hypertension, in the 
interest of safety, we conservatively defined appropriate exer-
cise as 20 minutes of moderate intensity exercise for at least 
3 days a week. We defined medication adherence as ≥80% 
adherence,23 which we operationalized as taking the medica-
tion as prescribed >5 days per week. Participants in HEI had 
monthly telephone counseling (duration of ≈15 minutes) where 
they received nontailored information about hypertension, and 
guidelines for diet, medication, and exercise in hypertension 
from American Heart Association educational materials24 and 
had a chance to ask questions. An additional health topic was 
added each month to approximate the amount of time and 
attention given to SMI participants.
Statistical Analyses
The outcomes were BP control (dichotomous: controlled or 
uncontrolled) and SBP (continuous); BP was measured at the 
0-, 6-, and 12-month visits. The analysis was conducted in sev-
eral steps. First, χ2 and Kruskal-Wallis tests were performed to 
evaluate if BP control and SBP at month 0 among the random-
ized arms were balanced. Second, McNemar test for BP con-
trol and the Wilcoxon signed-rank test for SBP were applied to 
test if the changes between month 0, month 6, and month 12 
were significant within the SMI, HEI, and UC arms. To evaluate 
sustainability of BP control, we tested the null hypothesis that 
the change in BP control (or SBP) is similar in the interven-
tion and control groups.25,26 Third, generalized estimating equa-
tions (GEEs) with logit link function were fitted to analyze the 
repeated measures of BP control (at both 6- and 12-month 
intervals), with 0-month BP control, treatment assignment, 
time, and interaction between treatment and time as covariates. 
Similarly, GEE models were applied to analyze continuous SBP 
with repeated measurements at 6- and 12-month intervals, 
adjusting for 0-month BP.
Fourth, to address the influence of missing data, we used 
multiple imputations under missing-at-random assumption, 
along with sensitivity analyses under missing-not-at-random 
assumption. We used multiple imputation with P summarized 
from 100 imputed datasets generated from an imputation model 
that included those variables that differed between those with 
missing and those without missing data. To obtain more robust 
estimates for standard errors from the multiple imputations, 
we also increased the number of imputations to 1000, and the 
results did not change. We also conducted a propensity-type 
analysis based only on patients being followed. To conduct this 
propensity analysis, we modeled the probability of missing at 6 
and 12 months and then reweighted the observations by the 
probability of missing in the model. Then, we used weighted 
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inverse probability-weighted method to account for missing 
data under the missing at random assumption.27,28
Finally, to examine if the effect of the interventions on BP 
control varied among prespecified subgroups, we conducted 
subgroup analyses where we examined whether the effect 
of the interventions on BP control varied among specific 
subgroups.
All statistical tests were evaluated at the 5% significance 
level, and all P are 2-sided. All analyses were intent-to-treat 
and were performed using SAS 9.4.
RESULTS
We screened and enrolled 705 adults with repeated 
uncontrolled BP of whom 548 participants success-
fully navigated the 1-month run-in period. Another 15 
participants were cancelled after the month 0 visit but 
before randomization for a total cancellation rate of 
24.4% (172 participants). We randomized 533 par-
ticipants of whom 481 completed the 6-month visit 
and 467 completed the 12-month visit, resulting in a 
6-month missing data rate of 9.8% and a 12-month 
missing data rate of 11.6% (Figure 1).
The proportion of participants with controlled hyper-
tension at baseline (month 0) after the 1-month run-in 
period among the SMI, HEI, and UC groups were 43%, 
41%, and 45%, respectively. There were no significant 
differences in BP control between the 3 groups at month 
0 (P=0.74). The mean SBP in mm Hg (with SD) at month 
0 for SMI, HEI, and UC was 136 (SD=14), 137 (SD=18), 
and 137 (SD=15), respectively; no significant differences 
were found (P=0.66; Table 1). At 6 months, there was 
significantly better BP control in SMI (62.3%) compared 
with UC (46.5%); HEI (52.4%) was not significant. The 
0-, 6-, and 12-month BP control rates and SBP levels are 
shown in Table 2. To evaluate sustainability of BP control 
from 6 to 12 months, we tested the null hypothesis that 
the change in BP control from 6 to 12 months is simi-
lar in the intervention and control groups. There was no 
significant change for any of the groups. Similarly, there 
was no significant change in SBP from 6 to 12 months 
for any of the groups. We further evaluated sustainability 
of the effect by testing the significance of the interaction 
between time and treatment, which was not significant 
in either GEE model indicating the change in BP control 
rate or systolic blood pressure from 6 to 12 months is not 
significantly different among the randomized groups.
Table 3 shows the mean effect of the interven-
tions on BP control evaluated using GEE to analyze 
the repeated measure of BP control and adjusting for 
month 0 BP control. The SMI resulted in improved BP 
control over the duration of the trial compared with 
UC (P=0.001), with SMI having 84% greater odds of 
having BP under control (odds ratio, 1.84 [95% CI, 
1.28–2.67). HEI also led to overall improvement in BP 
control compared with UC (P=0.04), with HEI having 
48% greater likelihood of bringing BP under control 
(odds ratio, 1.48 [95% CI, 1.02–2.14]). When control-
ling for month 0 BP control, there was no significant 
difference in BP control between 6 and 12 months for 
SMI (P=0.86), HEI (P=0.07), or UC (P=0.25).
Table 4 depicts the mean effect of the interventions 
on SBP evaluated using GEE to analyze the repeated 
measure of SBP and adjusting for month 0 BP control. 
The mean effect of SMI was 2.8 mm Hg (95% CI, 0.27–
5.33) lower than UC (P=0.03), while the mean effect of 
HEI was 2.6 mm Hg (95% CI, −0.40 to 5.55) lower com-
pared with UC (P=0.09).
Because of loss to follow up, ≈7% to 12.5% of the 
data was missing at the 6-month follow-up and 10% to 
13% at 12-month follow-up. We compared the sociode-
mographic, clinical, and comorbidity data (diabetes, heart 
attack, revascularization, hyperlipidemia, and estimated 
glomerular filtration rate) between those who completed 
and those who did not complete the follow-up visits. We 
used multiple imputation to conduct further analyses that 
incorporated missing data, with P summarized from one 
hundred imputed datasets generated from an imputation 
model that included those variables that differed between 
those with missing and those without missing data.29 
These variables were study group, race, hyperlipidemia, 
diet stage of change, exercise stage of change, and the 
number of medicines. Sensitivity analysis was also con-
ducted by comparing the results under the missing-at-
random assumption and the results under a scenario less 
favorable to the intervention arm. The results are sum-
marized in Table 5 where we compare the findings from 
3 putative missing data mechanisms: (1) missing com-
pletely at random using only the completed observations, 
(2) missing at random, and (3) missing not at random. For 
the third missing mechanism, we considered a scenario, 
which was less favorable to the interventions, that is, the 
missing observations in SMI and HEI were assumed to 
follow the same pattern as that of completed observa-
tions in UC.30 We found that the intervention effects esti-
mated under missing at random were generally bigger 
than those under missing completely at random, while the 
effects under the less favorable sensitivity analysis sce-
nario (UC) were slightly smaller than those under missing 
completely at random. These indicated that the results 
were not sensitive to the missing mechanisms.
To assess whether the overall effect of the interven-
tions on BP control varied among subgroups, we con-
ducted within-subgroup analyses (Figures 2 and 3) 
where we restricted the sample to all participants in the 
subgroup and compared SMI (or HEI) to UC using logis-
tic regression. All statistically significant comparisons 
are marked with asterisks. SMI had higher BP control 
rates than UC for 16 of the 22 comparisons across dif-
ferent characteristics (Figure 2A) while HEI had higher 
BP control rates than UC for 4 of the 22 comparisons 
(Figure 2B), with the magnitude of the effect (OR point 
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estimate) being consistently smaller for the HEI versus 
UC comparisons than for the SMI versus UC compari-
sons. Finally, to evaluate if there were significant differ-
ences between subgroups, we tested the interaction 
terms between treatments and the candidate subgroup 
variable in the GEE models. Between subgroup compari-
sons were not significant, except for the different tenden-
cies in working versus nonworking participants (P=0.04).
To understand which specific behavior change was 
driving the improvements in BP, we looked at the change 
in BP-related behaviors (ie, dietary approaches to stop 
hypertension score for diet, Morisky score for medica-
tion use, and physical activity) from 0 to 6, 6 to 12, and 0 
to 12 months (Table S1 in the Data Supplement). Mean 
scores for diet and medication use did increase from 0 
to 12 months for SMI and HEI, but changes were only 
significant for medication use. Within-group mean scores 
for medication use did increase from 0 to 12 months 
for all 3 groups. However, the BP reduction in the inter-
vention groups was not driven by medication intensifica-
tion (increasing the dose of existing medication or the 
addition of new medications) by the clinician. To further 
evaluate the clinician effect, we conducted GEE analysis 
in which patients within the same clinician are correlated 
as well as the repeated measures within patient are cor-
related, that is, a random effect for the clinician and for 
patients nested within clinicians. From the GEE, the cor-
relation between patients within clinician was very non-
significant. In addition, we evaluated the effect of the SMI 
and HEI in participants with and without controlled BP at 
baseline (Table S2). The SMI versus UC comparison over 
12 months was significant for both veterans with and 
without controlled BP at 0 months, while the HEI versus 
UC comparison over 12 months was only significant for 
veterans with uncontrolled BP at 0 months.
DISCUSSION
This trial evaluated the intervention effect (effective-
ness over 12 months) and sustainability (6 months 
after stopping intervention) of 2 telephone-delivered 
behavioral interventions on BP control and SBP among 
veterans with persistent uncontrolled hypertension 
in the primary-care setting. There were no significant 
differences between the SMI, HEI, or UC at month 0. 
We enrolled only patients with repeated uncontrolled 
Figure 1. CONSORT diagram with flow of participants from enrollment through 12 mo.
The figure shows the number screened and enrolled with repeated uncontrolled blood pressure (BP), the number who successfully 
navigated the 1-month run-in period and the number randomized for a total cancellation rate of 24.4% (172 participants) before 
randomization. It depicts the number (n=481) who completed the 6-mo visit and the number (n=467) who completed the 12-mo visit, 
resulting in a 6-mo missing data rate of 9.8% and a 12-mo missing data rate of 11.6%. HEI indicates health education intervention; SMI, 
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BP (per documented history from primary care visits). 
At month 0, fewer than half of the participants in each 
group had their BP under control. At 6 months, par-
ticipants in SMI increased their BP control and lowered 
their SBP, with a similar effect being observed in HEI, 
although without reaching statistical significance. From 
6 to 12 months, participants in SMI sustained their 
improved BP control and lower SBP, while participants 
in HEI were also able to sustain and further improve 
their BP control and SBP. Over 12 months, participants 
in both SMI and HEI increased their BP control and 
lowered their SBP.
Our results suggest that telephone counseling, uti-
lizing either the tailored transtheoretical intervention 
or (to some extent) the nontailored health education 
intervention, enabled participants to lower SBP and 
control BP relative to the usual-care group between 0 
and 6 months, and to sustain control for an additional 6 
months after the intervention was stopped. Mean SBP 
for SMI decreased at 6 months (from 136 at month 0 
to 131 mm Hg at month 6) and continued to decline at 
12 months (130 mm Hg). Similarly, mean SBP for HEI 
decreased at 6 months (from 137 to 132 mm Hg) and 
at 12 months mean SBP was 131 mm Hg. In light of the 
Table 1. Characteristics of Participants by Randomization Group at Baseline for Intervention and Sustainability
Variables










(N=168) UC (N=159) P
Sociodemographic and clinical characteristics
 Age, y; mean (SE) 66.4 (0.66) 66.5 (0.96) 65.4 (0.76) 0.50 66.7 (0.88) 66.4 (0.84) 65.5 (0.80) 0.56
 Male, % 98.9 99.4 97.7 0.36 98.7 99.4 97.5 0.34
 Race    0.33    0.43
  White (Non-Hispanic) 46.0 33.9 39.6  48.1 35.7 41.5  
  Black (Non-Hispanic) 36.9 43.3 39.0  35.7 43.5 39.0  
  Hispanic 13.6 16.1 15.8  12.3 14.3 15.1  
  Other 3.4 6.1 5.7  3.9 6.6 4.4  
 Married, % 33.5 38.0 39.1 0.58 35.1 36.9 38.5 0.83
 High school grad or below, % 40.8 50.3 48.3 0.15 40.8 47.9 48.1 0.34
 Employed 16.3 22.9 22.5 0.25 14.7 22.8 22.6 0.13
 Manhattan Campus, % 54.6 54.4 53.7 0.98 55.2 55.4 54.1 0.97
 Body mass index, mean (SE) 30.5 (0.38) 31.2 (0.47) 30.0 (0.34) 0.12 30.6 (0.43) 30.9 (0.46) 29.7 (0.37) 0.16
 Current smoker, % 20.1 18.3 17.9 0.87 19.0 18.1 16.4 0.83
 Comorbidities
  Diabetes, % 40.3 46.7 45.2 0.51 39.6 45.2 44.0 0.57
  IHD (heart attack), % 13.1 12.2 13.0 0.96 13.1 11.9 11.3 0.89
  Revascularization, % 15.3 16.1 17.1 0.93 16.2 16.1 15.2 0.96
  Hyperlipidemia, % 22.0 21.6 28.7 0.86 17.7 19.7 25.9 0.22
  EGFR, mean (SE) 79.9 (1.92) 83.2 (3.48) 80.6 (2.11) 0.74 79.4 (2.11) 83.7 (3.94) 81.1 (2.23) 0.75
Baseline BP and BP-related behaviors
 BP control, % 42.6 40.6 44.6 0.50 62.3 52.4 46.5 0.02
 Systolic blood pressure, mm Hg, mean (SE) 136.0 (0.89) 137.2 (1.33) 137.0 (0.96) 0.65 131.2 (1.18) 131.7 (1.30) 133.9 (1.17) 0.13
 Diastolic blood pressure, mm Hg, mean (SE) 75.5 (0.70) 76.1 (0.87) 75.0 (0.83) 0.66 72.2 (1.01) 72.6 (0.96) 73.2 (0.99) 0.51
 Aerobic exercise, h/wk, mean (SE) 5.3 (0.61) 4.5 (0.44) 5.0 (0.50) 0.48 4.6 (0.36) 4.8 (0.54) 4.3 (0.32) 0.73
 DASH score, mean (SE) 23.6 (0.47) 23.8 (0.45) 24.0 (0.42) 0.77 24.2 (0.49) 23.9 (0.48) 23.5 (0.46) 0.55
  Medication adherence by Morisky scale, 
mean (SE)
3.4 (0.07) 3.2 (0.05) 3.3 (0.07) 0.45 3.6 (0.06) 3.5 (0.06) 3.5 (0.06) 0.12
  Number of antihypertensive medications, 
mean (SE)
2.7 (0.11) 2.8 (0.10) 2.7 (0.10) 0.58 2.7 (0.12) 2.9 (0.11) 2.7 (0.11) 0.11
 Proportion (%) in action or maintenance for:
  Diet 39 38 39 0.99 56 46 43 0.06
  Exercise 71 62 60 0.07 82 78 74 0.25
  Medications 93 96 92 0.42 95 98 96 0.43
BMI indicates body mass index; BP, blood pressure; EGFR, estimated glomerular filtration rate; HEI, health education intervention; IHD, ischemic heart disease; SE, 
standard error; SMI, stage-matched intervention; and UC, usual care.
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fact that just a 2.2 mm Hg SBP reduction is associated 
with a 4% reduction in coronary death and a 6% reduc-
tion in stroke death during middle age,31,32 this reduction 
is clinically significant.
A Cochrane review of 72 RCTs that focused on 
improving BP through different approaches reported 
that the success achieved in most is modest and fur-
ther evaluation was needed.33,34 Interventions utilizing 
behavioral counseling were not included, and edu-
cational interventions alone were considered insuf-
ficient for achieving a large net reduction in BP. Our 
study thus adds to the literature on BP interventions 
by incorporating state-of-the-art behavioral theory 
and intervention processes to improve adherence to 
lifestyle changes.
This trial has several important strengths. First, we 
prioritized patients with persistent uncontrolled BP and 
monitored both the immediate and sustained effects 
of the intervention as part of the clinical trial. The tradi-
tional approach (UC) has proven ineffective in reducing 
BP and remote behavioral interventions present a good 
alternative. It is estimated that $51.2 billion is spent both 
directly and indirectly on high BP. Thus, the widespread 
use of behavioral interventions could ease some of this 
economic burden. Moreover, other studies have shown 
potential sustainable effects of interventions on chronic 
disease risk factor levels.35–37 Second, we focused on 
improving multiple aspects of dietary behavior as well as 
medication adherence and exercise through an interven-
tion approach informed by the Transtheoretical Model. 
Third, even though we only had a small proportion of 
missing data, we used missing data methods currently 
recommended for trial analysis, and thus the statistical 
inferences were robust.38
Table 2. BP Control and SBP Along With Change in BP Control and SBP Between Arms and Within Each Arm
Study 
arm 0 mo 6 mo 12 mo




∆ 6–12 mo 
within arm 
(P value) 




D-D 0–6 mo (95% CI; 
P value) between arms
D-D 6–12 mo (95% 
CI; P value) between 
arms
D-D 0–12 mo (95% 
CI; P value) between 
arms
BP control at 0, 6, and 12 mo with comparisons (McNemar test for within-group and t-test for between group)






SMI vs UC: 18.42% 
(5.6% to 1.3%; 0.005)
SMI vs UC: −5.3% 
(−18.4% to 7.9%; 0.43)
SMI vs UC: 13.2% 
(−0.4% to 26.8%; 0.06)






HEI vs UC: 12.8% 
(−0.02% to 25.6%; 0.05)
HEI vs UC: 1.8% 
(−10.8% to 14.5%; 0.78)
HEI vs UC: 14.6% 
(1.1% to 28.1%; 0.03)




















SMI vs UC: −1.94 
(−5.47 to 1.60; 0.28)
SMI vs UC: 0.16 
(−3.21 to 3.53; 0.93)
SMI vs UC: −1.78 













HEI vs UC: −2.51 
(−6.63 to 1.62; 0.23)
HEI vs UC: 0.46 
(−3.41 to 4.32; 0.82)
HEI vs UC: −2.05 














Difference-in-difference (D-D) BP control comparisons between SMI and HEI for 0 to 6 mo was 5.6% (−7.9% to 19.2%; 0.41); 6 to 12 mo −7.1% (−19.4% to 5.2%; 
0.26); and 0 to 12 mo −1.5% (−14.6% to 11.7%; 0.83). The D-D SBP comparisons (in mm Hg) between SMI and HEI for 0 to 6 mo was 0.57 (−3.45 to 4.59; 0.78); 6 
to 12 mo −0.30 (−4.21 to 3.62; 0.88); and 0 to 12 mo 0.27 (−4.30 to 4.85; 0.91). BP indicates blood pressure; HEI, health education intervention; SBP, systolic blood 
pressure; SMI, stage-matched intervention; and UC, usual care.
Table 3. Longitudinal Analysis of Intervention Effectiveness 
and Sustainability: Effect on BP Control
Comparison Odds ratio 95% CI P value
BP control (dichotomous variable)
 SMI vs UC (over 12 mo) 1.84 1.28–2.67 0.001
 HEI vs UC (over 12 mo) 1.48 1.02–2.14 0.04
 SMI vs HEI (over 12 mo) 1.25 0.85–1.83 0.26
 12 vs 6 mo for SMI 0.97 0.64–1.45 0.86
 12 vs 6 mo for HEI 1.41 0.98–2.04 0.07
 12 vs 6 mo for UC 1.28 0.84–1.93 0.25
The covariates in the GEE models were treatment arms, time points (6 and 
12 mo), the interaction between treatments and time points, and baseline BP 
control. BP was measured at 0, 6, and 12 mo. BP indicates blood pressure; GEE, 
generalized estimating equation; HEI, health education intervention; SMI, stage-
matched intervention; and UC, usual care. 
Table 4. Longitudinal Analysis of Intervention Effectiveness 
and Sustainability: Effect on Systolic BP
Comparison
Mean  
difference 95% CI P value
Systolic BP (continuous variable)
 SMI vs UC (over 12 mo) −2.80 −5.33 to −0.27 0.03
 HEI vs UC (over 12 mo) −2.58 −5.55 to 0.40 0.09
 SMI vs HEI (over 12 mo) −0.22 −3.25 to 2.80 0.89
 12 vs 6 mo for SMI −0.64 −3.67 to 1.67 0.57
 12 vs 6 mo for HEI −0.64 −3.67 to 2.39 0.68
 12 vs 6 mo for UC −0.97 −3.27 to 1.32 0.41
The covariates in the GEE models were treatment arms, time points (6 and 
12 mo), the interaction between treatments and time points, and baseline BP 
control. BP was measured at 0, 6, and 12 mo. BP indicates blood pressure; GEE, 
generalized estimating equation; HEI, health education intervention; SMI, stage-
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Despite the strengths, certain potential limita-
tions need to be noted. First, notwithstanding our 
best efforts, there is a small proportion of missing 
data (Figure 1). This was primarily due to the fact 
that some participants were not able to attend all vis-
its (ie, 6 and 12 months). Second, this randomized 
trial was not powered to test comparisons between 
the active intervention arms. However, if both inter-
ventions are successful, the findings would allow a 
hospital or clinic to use the appropriate intervention 
based on their resources and needs. In some set-
tings, implementing the tailored intervention will be 
feasible and justified by local resources and the high 
prevalence of uncontrolled hypertension; in other 
settings, there may not be the expertise or resources 
to feasibly deliver the tailored intervention, and thus a 
simpler intervention may be a viable alternative. Third, 
certain subgroups may not benefit from either of the 
interventions, in particular, those who were working 
and thus could not fully participate in the interven-
tion. Further research is needed to find tailored inter-
ventions that will target their needs.
Although we enrolled patients with 2 consecu-
tive uncontrolled BP measurements on 2 different 
days, 41% to 45% had controlled BP at the base-
line visit. This could be because of regression to the 
mean, provider treatment intensification, placebo 
effects, or patient activation after enrollment. The 
run-in period allows us to account for regression to 
the mean effects. Other potential confounders should 
be equally distributed between the groups because 
of randomization. Importantly, there were no signifi-
cant BP differences between groups at baseline. To 
reduce the likelihood of bias further, we took provid-
ers into account and controlled for baseline BP in all 
analyses. Although we enrolled patients who were 
uncontrolled at the baseline, anticipating regression 
to the mean, our actual power analysis assumed the 
BP control rate of 43% in UC at the baseline, which 
is consistent with what happened. The proportion of 
drop outs was also lesser than what we expected, 
which improved the power of the study.
Our findings should be interpreted while taking into 
account the study setting and design. Our sample is 
representative of US veterans with hypertension living 
in an urban environment (ie, being primarily male, older, 
and with multiple comorbidities). The Veterans Health 
Administration is the largest health maintenance orga-
nization in the United States and hypertension is a major 
issue in non-Veterans Administration and non-Health 
Maintenance Organization (HMO) settings throughout 
the United States and the world. Thus, these findings 
likely can be generalized to other managed-care set-
tings that possess similar organizational characteristics 
and patient populations. While gains in hypertension 
control have been achieved using system and provider 
efforts, concerns remain that non-targeted behavioral 
approaches may lead to overtreatment and potential 
adverse events.39 Therefore, a strategy that focuses 
on patients with persistent uncontrolled hypertension 
and tailors counseling to patients’ behaviors to improve 
adherence and achieve BP targets has great promise. 
Moreover, the coronavirus disease 2019 (COVID-19) 
pandemic has created an immediate need for novel 
remote interventions for vulnerable and isolated popu-
lations. In addition to telephone-based intervention, 
both SMI and HEI could be adapted for interactive 
voice response, texting or other digital health commu-
nication technologies.
PERSPECTIVES
The telephone-delivered, SMI we evaluated resulted in 
statistically significant and clinically meaningful improve-
ments in BP at 6 months, with sustained benefits over 
12 months. By comparison, the telephone-delivered HEI 
was nearly as effective over 12 months. Importantly, 
the interventions did not involve in-person contact; this 
increases the potential reach and scalability of these 
approaches and should reduce costs. Thus, we think SMI 
and HEI constitute valuable intervention approaches for 
improving BP control rates. Health care settings with 
the resources to train staff in transtheoretical model-
based counseling should use the SMI while health care 
Table 5. Effects of SMI vs UC and HEI vs UC on BP Control and SBP Under Different Missing Data Scenarios









BP control (yes/no) SMI vs UC 1.85 (OR) 0.001 1.85 0.001 1.91 0.0007 1.73 0.004
HEI vs UC 1.48 (OR) 0.04 1.48 0.04 1.46 0.04 1.43 0.06
Systolic BP, mm Hg SMI vs UC −2.80 0.03 −2.82 0.03 −2.96 0.03 −2.52 0.06
HEI vs UC −2.58 0.09 −2.50 0.10 −2.58 0.10 −2.31 0.13
The multiple imputation model used the following variables to impute BP at 6 and 12 mo sequentially: race, hyperlipidemia status, DSOC, ESOC, number of medication, 
baseline BP, time points, and treatment arms. MCAR missing completely at random; MAR missing at random; MNAR missing not at random. BP indicates blood pressure; 
DSOC, dietary stage of change; ESOC, exercise stage of change; HEI, health education intervention; MAR, missing at random; MCAR, missing completely at random; 
MNAR, missing not at random; OR, odds ratio; SBP, systolic blood pressure; SMI, stage-matched intervention; and UC, usual care.
*MNAR is under a less favorable usual care sensitivity analysis scenario than the intervened groups, where the missing observations in SMI and HEI were assumed 
to follow the same distribution as that of completed observations in the UC group.
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settings with limited resources could use the HEI. Either 
approach represents the proactive approach necessary 
to provide patients with uncontrolled hypertension with 
the additional behavioral self-management skills that are 
critical to achieve BP control.
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Figure 2. Odds ratios (ORs) for 
blood pressure control among 
key participant subgroups and all 
participants.
These subgroup analyses evaluate how 
well the interventions worked in important 
subgroups and are within-subgroup 
comparisons of intervention and control 
groups. The sample was restricted to 
each subgroup, and within each subgroup 
stage-matched intervention (SMI) (or 
health education intervention [HEI]) was 
compared with usual care (UC) using 
logistic regression. Top A, SMI arm 
compared with UC (*P<0.05). Lower B, 
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